Israel Englander Repligen Corp Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Repligen Corp stock. As of the latest transaction made, Millennium Management LLC holds 701,239 shares of RGEN stock, worth $85.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

701,239

Previous 19,897 3424.35%

Holding current value

$85.1 Million

Previous $2.53 Million 3346.07%

% of portfolio

0.05%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$108.89 - $145.23 $74.2 Million - $99 Million	681,342 Added 3424.35%	701,239 $87.2 Million
Q1 2025 May 15, 2025	BUY	$127.24 - $174.24 $1.34 Million - $1.84 Million	10,566 Added 113.24%	19,897 $2.53 Million
Q4 2024 Feb 14, 2025	SELL	$123.41 - $160.92 $13.6 Million - $17.7 Million	-110,079 Reduced 92.19%	9,331 $1.34 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $76.3 Million - $107 Million	-636,708 Reduced 84.21%	119,410 $17.8 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $90.7 Million - $138 Million	756,118 New	756,118 $95.3 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $13.3 Million - $21.5 Million	116,110 Added 1110.36%	126,567 $22.8 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $2.38 Million - $3.11 Million	-17,226 Reduced 62.23%	10,457 $1.48 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $4.27 Million - $5.48 Million	27,683 New	27,683 $4.66 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $4.6 Million - $7.35 Million	-28,680 Reduced 20.43%	111,687 $20.9 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $19.1 Million - $25.5 Million	135,725 Added 2923.85%	140,367 $22.8 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $49.1 Million - $78.6 Million	-304,840 Reduced 98.5%	4,642 $873,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $46.1 Million - $56.7 Million	186,342 Added 151.33%	309,482 $82 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $35.3 Million - $58.7 Million	-181,113 Reduced 59.53%	123,140 $35.6 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $14.4 Million - $19.2 Million	86,796 Added 39.91%	304,253 $60.7 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $25 Million - $31.4 Million	138,605 Added 175.78%	217,457 $42.3 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $1.52 Million - $2.12 Million	-10,242 Reduced 11.5%	78,852 $15.1 Million
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $27 Million - $34.9 Million	-220,619 Reduced 71.23%	89,094 $13.1 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $29.2 Million - $43.5 Million	309,713 New	309,713 $38.3 Million
Q1 2020 May 14, 2020	SELL	$84.96 - $109.14 $1.51 Million - $1.94 Million	-17,791 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $582,892 - $734,773	-7,894 Reduced 30.73%	17,791 $1.65 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $813,793 - $1.01 Million	10,617 Added 70.46%	25,685 $1.97 Million
Q2 2019 Aug 15, 2019	SELL	$54.2 - $85.95 $491,431 - $779,308	-9,067 Reduced 37.57%	15,068 $1.3 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $1.4 Million - $2.22 Million	-25,871 Reduced 51.74%	24,135 $3.42 Million
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $7.86 Million - $9.98 Million	-158,970 Reduced 76.07%	50,006 $2.95 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $10.1 Million - $14.4 Million	208,976 New	208,976 $11 Million
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $1.62 Million - $2.04 Million	-34,609 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $1.22 Million - $1.63 Million	34,609 New	34,609 $1.63 Million

Others Institutions Holding RGEN

# of Institutions

502

Shares Held

58.2M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.74B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account